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Monitoring the spread of HIV in populations would greatly 
benefit from a practical method that could identify recently 
infected persons.  Ideally, HIV spread and changes over 
time should be tracked through measuring the number and 
distribution of new infections, i.e. incidence, in a population.  
Incidence measures are generally better than prevalence 
measures for assessing the dynamics of HIV transmission in 
different populations.1  Incidence is the key indicator of the rate 
of HIV transmission and provides the most direct means of 
assessing the impact of HIV prevention programmes.
True incidence data, however, can only be obtained through 
large-scale cohort studies.  Such studies have many drawbacks, 
including cost, ethical considerations, participation and/or 
selection biases and the fact that those included in a cohort 
will inevitably have more exposure to HIV programmes 
or intervention efforts. As a consequence, HIV incidence 
estimation has mostly been provided by mathematical 
models.2-4  Indirect HIV incidence estimates have also been 
derived from prevalence surveys in young people (15 - 24 
years) using prevalence data by single year of age and 
assuming that HIV prevalence differences between the age 
strata represent incident HIV infections.5  However, this 
method is not applicable in older age groups, in which AIDS-
related mortality has a major impact on HIV prevalence levels. 
The complexities and limitations of epidemiological 
approaches to measure HIV incidence argue strongly for a 
laboratory-based method that can distinguish recent from 
established long-term HIV infections, independent of the age of 
the source population. Several laboratory-based methods have 
been developed that are based on the events of early HIV-1 
infection.6-8  The underlying principle is that the response of a 
person to HIV during the early infection stage can be timed by 
the presence or absence of markers in that person’s blood (Fig. 
1). These unique and specific host responses to HIV infection 
enable the estimation of HIV incidence based on laboratory 
assays using blood specimens from cross-sectional rather than 
longitudinal survey designs. 
Over the past years, the Centers for Disease Control and 
Prevention (CDC) introduced the BED capture enzyme 
immunoassay (CEIA) assay to identify incident infection. 
The BED assay uses a multi-subtype synthetic peptide and 
measures the increasing proportion of HIV-IgG to total 
IgG after seroconversion (Fig. 1). The assay is designed to 
work well in populations with different HIV-1 subtypes and 
the testing algorithm has been successfully evaluated in 
populations in the USA and Thailand with B and E subtypes, 
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Background and objectives. Currently South Africa does not 
have national HIV incidence data based on laboratory testing 
of blood specimens. The 2005 South African national HIV 
household survey was analysed to generate national incidence 
estimates stratified by age, sex, race, province and locality type, 
to compare the HIV incidence and HIV prevalence profiles by 
sex, and to examine the relationship between HIV prevalence, 
HIV incidence and associated risk factors. 
Method. The detection of recent infections was performed 
on confirmed HIV-positive samples, using the BED capture 
enzyme immunoassay optimised for dried blood spot (DBS) 
specimens. BED HIV incidence calculations applied adjustment 
procedures that were recently revised and approved by the 
Centers for Disease Control and Prevention for subtype C blood 
specimens.
Results. HIV incidence in the study population aged 2 years 
and older was 1.4% per year, with 571 000 new HIV infections 
estimated for 2005. An HIV incidence rate of 2.4% was recorded 
for the age group 15 - 49 years. The incidence of HIV among 
females peaked in the 20 - 29-year age group at 5.6%, more than 
six times the incidence found in 20 - 29-year-old males (0.9%). 
Among youth aged 15 - 24 years, females account for 90% of 
the recent HIV infections. Non-condom use among youth, 
current pregnancy and widowhood were the socio-behavioural 
factors associated with the highest HIV incidence rates.
Conclusions. The HIV incidence estimates reflect the 
underlying transmission dynamics that are currently at work in 
South Africa. The findings suggest that the current prevention 
campaigns are not having the desired impact, particularly 
among young women.
S Afr Med J 2007; 97: 194-199.
March 2007, Vol. 97, No. 3  SAMJ
Pg 194-199.indd   194 2/16/07   2:26:25 PM
ORIGINAL ARTICLES
195
as well as in cohorts from the Netherlands, Kenya, Ethiopia, 
Zimbabwe and India which comprise A, B, C and D  
subtypes.7-10
In December 2005, the UNAIDS Reference Group on 
Estimates, Modeling and Projections issued a statement in 
response to preliminary data from population surveys and 
selected validation studies which demonstrated that the 
BED assay overestimated HIV-1 incidence by misclassifying 
a number of individuals with long-term infection as recent 
infection in cross-sectional settings.11  In May 2006, the CDC’s 
Surveillance and Survey and Laboratory working groups 
reviewed new study results and proposed adjustments to 
estimate HIV-1 incidence using the BED CEIA. Data were 
presented from China, Côte d’Ivoire, South Africa, Thailand, 
Uganda, the USA and Zimbabwe to address the concerns 
expressed by the UNAIDS Reference Group. On the basis of 
its review of the study results, the working groups developed 
guidelines with detailed adjustment procedures for the 
estimation of HIV-1 incidence in cross-sectional, population-
based serosurveys.12,13
The 2005 South African national household survey on HIV, 
Behaviour and Communication included HIV incidence testing 
in its survey protocol for the first time.14 Almost 16 000 blood 
specimens tested for HIV provided an unparalleled large 
sample to estimate HIV incidence on a national scale for South 
Africa. Using the adjusted BED HIV-1 incidence method, 
this paper presents national incidence estimates stratified by 
age, sex, race, province and locality type, compares the HIV 
incidence and HIV prevalence profiles for the male and female  
populations and examines the relationship between HIV 
prevalence, HIV incidence and associated risk factors. 
Methods 
Survey design and sampling
The survey targeted all persons over 2 years of age living in 
South Africa and residing in homes, i.e. excluding individuals 
living in educational institutions, old-age homes, hospitals 
and uniformed service barracks but including those living in 
hostels. The survey applied a multi-stage stratified sampling 
approach based on a master sample consisting of 1 000 
enumerator areas (EAs) used by Statistics South Africa for the 
national census in 2001. Three persons in each household were 
potentially eligible to be selected for the survey; however only 
one was selected from each of the age groups 2 -14 years, 15 - 
24 years, and 25 years and older. A total of 23 275 individuals 
aged 2 years and older participated in the 2005 survey and 
15 851 respondents agreed to be tested for HIV. Linked 
anonymous HIV testing was performed using dried blood 
spot (DBS) specimens. Socio-demographic and behavioural 
information was collected with questionnaires administered by 
trained fieldworkers.14 
HIV antibody testing
All samples were first tested with the Vironostika HIV-1 
Uniform II Plus O enzyme immunoassay (BioMerieux). All 
HIV-positive samples were retested with a second EIA (Vitros 
ECI, Ortho Clinical Diagnostics). A second test was also 
conducted for 10% of cases where the first test was negative. 
Samples testing positive in enzyme immunoassay 1 and 
negative in enzyme immunoassay 2 (producing discordant 
results) were submitted to a third enzyme immunoassay 
(Biorad HIV 1 + 2) for final interpretation of discordant 
samples.
BED HIV incidence
The detection of recent infections was performed on confirmed 
HIV-positive samples, using the BED CEIA (Calypte HIV-1 
BED Incidence EIA, Calypte Biomedical Corporation, Md, 
USA) optimised for DBS specimens. Adjustment procedures 
for BED HIV incidence calculation have been reviewed at a 
recent expert meeting at CDC/USA.12  The method described 
by McDougal et al.15 uses an adjustment formula that corrects 
for both false long-term infections (sensitivity) and false 
recent infections (specificity) determined by the BED CEIA.  
Annualised BED HIV incidence calculation applied a window 
period of 180 days for HIV subtype C specimens. 
Sensitivity/specificity adjusted BED HIV incidence formula:
                           (F) * (365/w) * R                                                            
              N + [(F) * (365/w) * (R/2)]    
BED HIV incidence is calculated as incidence percent per 
year (%/year). In order to provide national estimates, the HIV 
incidence calculation took into account the complex sampling 
design and used weighted numbers in the above formula 
(see section on data analysis below). The expression in the 
numerator of the formula was used to estimate the annual 
number of new HIV infections.
Fig. 1. Detection of early HIV infection (adapted from Parekh et al.7).
I   = x 100
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Calculation of the adjustment factor F:
             (R/P) + γ – 1                    
                   (R/P) (α – β + 2γ -1)
Ninety-five per cent confidence bounds were calculated as 
follows:
Symbols: 
I = incidence (number of new infections per year per 100 at 
risk)
F = adjustment factor for sensitivity/specificity adjustment 
P = total testing HIV positive
N = total testing HIV negative
R = total testing recent in the BED-CEIA
Deft = design effect.
Imputed values:
w = 180 (window in days)
α = 0.7682 (sensitivity of BED test for detecting recent (< w ) 
infection)
β = 0.7231 (specificity of the BED test over the period > w to < 
2 w)
γ = 0.9443 (specificity of the BED test over the period > 2 w).
Data analysis
Taking into account the complex sampling design and 
adjusting for HIV testing non-response, a weighted analysis of 
HIV prevalence, HIV incidence and behavioural characteristics 
was carried out for the reporting domains sex, age group, race, 
province and type of residence. Individual sample weights 
were benchmarked to produce a final weighted sample that 
closely matched the socio-demographic characteristics of the 
2005 mid-year population estimates provided by Statistics 
South Africa.16  Weighted data were analysed with STATA 8.0 
software. STATA (svy methods) was also used to obtain HIV 
prevalence estimates with confidence intervals (95% CI) that 
took into account the survey design. 
Results
Tables I and II present HIV incidence estimates for South Africa 
in both relative terms (% per year) and absolute terms (number 
of new infections per year). HIV incidence among persons 
aged 2 years and older is calculated at 1.4% per year (95% CI: 
1.0 - 1.8), with 571 000 new HIV infections estimated for 2005 
(Table I). The incidence of HIV in the child population aged 2 
- 14 years is of concern; a relative incidence of 0.5% (95% CI: 
0.0 - 1.2) translates to 69 000 estimated new infections in this 
age group. The HIV incidence for youth 15 - 24 years of age is 
higher than the incidence rate for people 25 years and older, 
2.2% (95% CI: 1.3 - 3.1) and 1.7% (95% CI: 1.1 - 2.3) respectively. 
An HIV incidence of 2.4% (95% CI: 2.2 - 2.7) and 500 000 new 
infections were estimated for the age group 15 - 49 years.  
Table II shows the calculated HIV incidence by race, 
province and locality type for the population 2 years and older. 
HIV incidence in the black race group is 9 times higher than 
the incidence found in the other race groups, with figures of 
1.8% (95% CI: 1.3 - 2.3) and 0.2% (95% CI: 0.0 - 0.3) respectively. 
Mpumalanga (2.4%, 95% CI: 0.9 - 3.8), Free State (1.9%, 95% 
CI: 0.4 - 3.4), Gauteng (1.9%, 95% CI: 0.8 - 3.0), KwaZulu-Natal 
(1.7%, 95% CI: 0.7 - 2.7) and Limpopo (1.6%, 95% CI: 0.3 - 2.8) 
recorded the highest incidence, while North West (1.0%, 95% 
CI: 0.2 - 1.8), Western Cape (0.8%, 95% CI: 0.2 - 1.5), Eastern 
Cape (0.7%, 95% CI: 0.1 - 1.2) and Northern Cape (0.2%, 95% 
CI: 0.0 - 0.4) had incidence rates of 1% and lower. In absolute 
terms, however, most new HIV infections occurred in the 
populous provinces of Gauteng and KwaZulu-Natal, totalling 
an estimated 144 000 and 134 000 respectively.
Persons living in urban informal settlements have by far the 
highest incidence rates (5.1%, 95% CI: 3.2 - 7.0) compared with 
those living in rural formal areas (1.6%, 95% CI: 0.7 - 2.5), rural 
informal areas (1.4%, 95% CI: 0.1 - 2.8) and urban formal areas 
(0.8%, 95% CI: 0.3 - 1.2). 
Fig. 2 compares the HIV incidence and HIV prevalence 
profile in the South African population by age and sex.  The 
differences in HIV incidence between males and females are 
especially large in the younger age groups under 30 years of 
age. HIV incidence among females rises fast and peaks in the 
20 - 29 age band at 5.6% (95% CI: 2.8 - 8.4), more than 6 times 
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Table I. HIV incidence and number of new infections* by age group, South Africa, 2005
Age group                                          HIV incidence (%per year)         Estimated number of new 
(yrs)          Weighted sample (N)                                  (95% CI)         infections per year (N)
> 2    44 513 000          1.4 (1.0 - 1.8)   571 000 
2 - 14    13 253 000          0.5 (0.0 - 1.2)     69 000
15 - 24        9 616 000          2.2 (1.3 - 3.1)   192 000
> 25    21 645 000          1.7 (1.1 - 2.3)   310 000 
15 - 49    24 572 000          2.4 (2.2 - 2.7)   500 000
   
*Numbers rounded off to the nearest thousand.
March 2007, Vol. 97, No. 3  SAMJ
Pg 194-199.indd   196 2/16/07   2:26:27 PM
ORIGINAL ARTICLES
197
the incidence found in males in this age group (0.9%, 95% CI: 
0.0 - 1.9). The incidence of HIV among males increases much 
more slowly than in females and peaks at a lower level in the 
30 - 39-year age group at 2.7% (95% CI: 0.0 - 5.7). 
These differential HIV transmission dynamics between 
males and females are reflected in the HIV prevalence profiles. 
HIV prevalence increases dramatically among young females 
and peaks at 28.2% (95% CI: 24.5 - 32.1) in the 20 - 29-year 
age group. In males the increase in HIV prevalence is more 
progressive, and peaks at 23.3% (95% CI: 18.9-28.3) 10 years 
later in the age group 30 - 39 years. 
Table III examines the relationship between HIV prevalence, 
HIV incidence and various socio-behavioural factors among 
15 - 49-year-olds. Individuals who were single were more likely 
to be HIV positive than those who were married, with a figure 
of 16.6% (95% CI: 14.9 - 18.5) versus 14.3% (95% CI: 12.3 - 16.6), 
and the incidence of HIV among single people was also higher 
at 3.0% (95% CI: 1.9 - 4.1) versus 1.3% (95% CI: 0.5 - 2.1). The 
prevalence of HIV among individuals who were widowed was 
considerably higher than for those who were either single or 
married, at 34.0% (95% CI: 25.5 - 43.7). Widowed individuals 
also had a considerably higher HIV incidence than individuals 
who were single or married, with a figure of 5.8% (95% CI: 0.0 - 
13.8). 
Individuals who were sexually active in the past 12 months 
recorded an HIV prevalence of 18.7% (95% CI: 17.0 - 20.6) and 
an HIV incidence of 2.4% (95% CI: 1.5 - 3.3). Interestingly, a 
substantial rate of recent HIV infections was also recorded 
in survey participants who reported that they never had sex 
(1.5%, 95% CI: 0.0 - 3.0) or no sex in the past 12 months (2.4%, 
95% CI: 0.8 - 4.1), illustrating contradictions between biological 
test results and self-reported sexual behaviour. Currently 
pregnant women were found to have among the highest 
prevalence and incidence rates, 37.0% (95% CI: 24.9 - 51.0) and 
5.2% (95% CI: 0.0 - 12.9), respectively. Individuals who reported 
only one sexual partner in the past year were less likely to 
be HIV positive in comparison with those who reported two 
or more partners, with a figure of 18.4% (95% CI: 16.7 - 20.4) 
versus 21.3% (95% CI: 15.9 - 28.0), and similarly had a lower 
HIV incidence, 2.1% (95% CI: 1.3 - 3.0) versus 3.1% (95% CI: 
0.0 - 6.4). 
Among young people aged 15 - 24 years, reported condom 
use at last sex is correlated with lower HIV prevalence, 14.2% 
(95% CI: 11.0 - 18.4) versus 20.8% (95% CI: 15.3 - 27.8), and 
Fig. 2. HIV incidence and HIV prevalence by age and sex, South Africa, 
2005.
Table II. HIV incidence and number of new infections* by race, province and locality type (age ≥ 2 years), South Africa, 2005
                  HIV incidence (% per year)   Estimated number of new
Variable                  Weighted sample (N)             (95% CI)   infections per year (N)
         
Race   
Black    35 113 000          1.8 (1.3 - 2.3)                557 000
Other      9 337 000          0.2 (0.0 - 0.3)                  14 000
Province    
Mpumalanga     3 083 000          2.4 (0.9 - 3.8)                  63 000
Free State     2 827 000          1.9 (0.4 - 3.4)                  47 000
Gauteng     8 512 000          1.9 (0.8 - 3.0)                144 000
KwaZulu-Natal    9 213 000          1.7 (0.7 - 2.7)                134 000
Limpopo     5 207 000          1.6 (0.3 - 2.8)                  76 000
North West     3 642 000          1.0 (0.2 - 1.8)                  33 000
Western Cape     4 382 000          0.8 (0.2 - 1.5)                  33 000
Eastern Cape     6 777 000          0.7 (0.1 - 1.2)                  40 000
Northern Cape        871 000          0.2 (0.0 - 0.4)                    1 000
Locality type   
Urban informal    3 878 000          5.1 (3.2 - 7.0)                166 000
Rural formal    3 577 000          1.6 (0.7 - 2.5)                  52 000
Rural informal   16 495 000          1.4 (0.1 - 2.8)                211 000
Urban formal  20 563 000          0.8 (0.3 - 1.2)                142 000
*Numbers rounded off to the nearest thousand.
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lower HIV incidence, 2.9% (95% CI: 0.5 - 5.2) versus 6.1% (95% 
CI: 0.0 - 12.9). This is in contrast to the findings in respondents 
aged 25 - 49, where HIV prevalence was significantly (p < 
0.001) higher among condom users (24.9%, 95% CI: 21.1 - 29.1) 
than in non-condom users (16.0%, 95% CI: 12.3 - 20.6) while 
HIV incidence was similar in these groups, 2.2% (95% CI: 0.4 
- 4.0) and 1.9% (95% CI: 0.0 - 3.7) respectively.
Discussion
The HIV incidence estimates reflect the underlying 
transmission dynamics that are currently at work in South 
Africa. It is important to keep in mind that HIV incidence is a 
point estimate of recent HIV infections, while HIV prevalence 
is the result of cumulative new infections over time minus the 
cumulative deaths among HIV-infected persons. 
Our analysis indicates that 571 000 new HIV infections 
occurred in the population 2 years and older during the year 
2005 in South Africa. Of all new HIV infections, 34% occurred 
in young people aged 15 - 24 years. The incidence rates among 
young females in their prime childbearing age are especially 
alarming. The HIV incidence among females in the 20 - 29 age 
group was 5.6%, more than 6 times that in males of the same 
age (0.9%). Among youth aged 15 - 24 years, females account 
for 90% of recent HIV infections. 
The incidence data show that new non-vertical infections 
have occurred among children in South Africa, confirming the 
findings of the 2002 Nelson Mandela/HSRC study of HIV/
AIDS.17  These infections in children between 2 and 14 years 
are probably not linked to mother-to-child transmission, and 
infection would therefore have occurred through other modes 
of transmission, potentially including child sexual abuse, 
scarification practices and health care services – a research 
topic that needs urgent attention. 
Place of residence is an important epidemiological variable 
because it embodies socio-economic contexts that influence 
risk of HIV infection. In South Africa, some black people live in 
contexts that increase vulnerability to many illnesses – and HIV 
is no exception. Although only 8.7% of the total South African 
population aged 2 years and above lives in urban informal 
settlements, 29.1% (166 000/571 000) of the total estimated 
number of new HIV infections in South Africa are found in this 
residence geotype. 
The analysis of condom use at last sex by age group 
illustrates that HIV incidence rather than HIV prevalence is 
the more appropriate measure to interpret the effects of recent 
behaviours on HIV infection. While more complex contextual 
measures of condom use are necessary for elaborating on the 
findings in the older age group, it is important to note that 
reported condom use at last sex in the younger age group is 
associated with lower HIV incidence.
The incidence analysis also found contradictions between the 
biological data and self-reported sexual behaviour, indicating 
some reticence in providing detailed information about sexual 
behaviour in a cross-sectional survey. For example, new 
Table III. HIV prevalence and incidence by self-reported socio-behavioural factors (age group 15 - 49 years)
     Survey sample          HIV prevalence (%)  HIV incidence (% per year)
Variable              (N)                (95% CI)                                (95% CI)
Marital status   
Single            5 306             16.6 (14.9 - 18.5)             3.0 (1.9 - 4.1)
Married           3 240             14.3 (12.3 - 16.6)             1.3 (0.5 - 2.1)
Widowed              227             34.0 (25.5 - 43.7)             5.8 (0.0 - 13.8)
Divorced              318             15.1 (9.5 - 23.0)             0.5 (0.0 - 1.6)
Sexual history   
Never had sex           1 747             4.3 (2.7 - 7.0)              1.5 (0.0 - 3.0)
No sex in the past 12 months         1 358             18.0 (14.9 - 21.5)              2.4 (0.8 - 4.1)
Sexually active in the past 12 months         5 803             18.7 (17.0 - 20.6)             2.4 (1.5 - 3.3)
Current pregnancy             215             37.0 (24.9 - 51.0)             5.2 (0.0 - 12.9)
Number of sexual partners   
One sex partner in the past 12 months        5 233             18.4 (16.7 - 20.4)             2.1 (1.3 - 3.0)
More than one sex partner in the past  
12 months             468             21.3 (15.9 - 28.0)             3.1 (0.0 - 6.4)
Condom use at last sex   
15 - 24 years   
Yes            1 011             14.3 [(11.0 - 18.4)             2.9 (0.5 - 5.2) 
No               392             20.8 (15.3 - 27.8)             6.1 (0.0 - 12.9) 
25 - 49 years   
Yes            1 049             24.9 (21.1 - 29.1)             2.2 (0.4 - 4.0)
No             1 068             16.0 (12.3 - 20.6)             1.9 (0.0 - 3.7)
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HIV infections were found in individuals who reported that 
they had had no sex in the past 12 months. Further analysis 
revealed that some of these individuals also reported that they 
had a recent sexually transmitted infection (2.5% of males, 
3.1% of females).   A surprising finding was the observed 
high incidence among some older sub-populations. Widowed 
individuals (median age 43 years, 79.6% females) had a 
remarkably high HIV incidence of 5.8%, pointing to a lack of 
perceived risk of HIV infection among older people in South 
Africa. Our analysis also supports recent findings from Uganda 
by Gray et al.18 that suggest an increased risk of HIV acquisition 
during pregnancy. Females aged 15 - 49 years who reported a 
current pregnancy in the survey were found to have an HIV 
incidence of 5.2%, compared with 3.8% in the non-pregnant 
female population 15 - 49 years of age. 
HIV incidence estimates derived with the BED methodology 
are the subject of ongoing validation research. Our HIV 
incidence analysis is based on the recommended adjustment 
for BED HIV incidence calculation that has been validated for 
subtype C specimens, the predominant HIV subtype in South 
Africa.12,13  The potential errors and biases associated with the 
BED assay methodology are expected to remain stable over 
time.1  This is important because the main purpose of incidence 
estimation is to measure trends in HIV incidence and relative 
differences in incidence in the same population or between 
subpopulations of the same population over time. 
Conclusion
The relationship between HIV incidence and prevalence grows 
increasingly complex as the epidemic matures and prevention 
and care efforts try to mitigate it at the same time. Incidence 
data provide critical new insights into the dynamics of the 
HIV epidemic and is a more appropriate measure to correlate 
biological data with recent behaviours or recent behavioural 
changes. The availability of laboratory-based tests for recent 
HIV infection also provides insights into the limits of self-
reported sexual behaviour in cross-sectional surveys. The 
2005 national HIV incidence estimates presented in this study 
will serve as benchmark figures for future assessments of the 
dynamics and trends of the South African HIV epidemic, and 
provide a mechanism for tracking the impacts of prevention 
interventions.
A number of areas require urgent further investigation, 
including evidence of new HIV infections among children aged 
2 - 14, and high HIV incidence among widowed persons. High 
incidence rates among females, among pregnant females, and 
among people living in informal settlements illustrate high 
levels of disproportionate risk. The highly resourced plethora 
of prevention programmes in South Africa has failed to address 
HIV incidence in these high-risk categories sufficiently, and 
more efficient and targeted interventions are clearly urgently 
required. 
The analysis was based on data from the South African National 
HIV Prevalence, HIV Incidence, Behaviour and Communication 
Survey, 2005, commissioned by the Nelson Mandela Foundation 
with additional support from the Centers for Disease Control 
and Prevention. BED incidence testing at the NICD Serology 
Laboratory was supported by the CDC cooperative agreement 
U62/CCU022901.
We thank Dr Lorna Madurai (Global Clinical Viral Laboratory, 
Durban) and Beverley Singh (NICD Serology Laboratory, 
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References
  1. McDougal SJ, Pilcher CD, Parekh BS, et al. Surveillance for HIV-1 incidence using test for 
recent infection in resource-constrained countries. AIDS 2005; 19 (suppl 2): S25-S30.
  2. The UNAIDS Reference Group on Estimates, Models and Projections. Estimating and 
Projecting National HIV/AIDS Epidemics. UNAIDS/01.83. Geneva: UNAIDS, 2002.
  3. Rehle T, Shisana O. Epidemiological and demographic HIV/AIDS projections: South Africa. 
African Journal of AIDS Research 2003; 2 (1): 1-8.
  4. Dorrington RE, Bradshaw D, Johnson L, et al. The Demographic Impact of HIV/AIDS in South 
Africa. National Indicators for 2004. Cape Town: Centre for Actuarial Research, South African 
Medical Research Council and Actuarial Society of South Africa, 2004.
  5. Gregson S, Machekano R, Donnelly CA, et al. Estimating HIV incidence from age-specific 
prevalence data: comparison with concurrent cohort estimates in a study of male factory 
workers, Harare, Zimbabwe. AIDS 1998; 12: 2049-2058.
  6. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection 
for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280: 42-
48
  7. Parekh B, Kennedy S, Dobbs T, et al. Quantitative detection of increasing HIV type 1 
antibodies after seroconversion: A simple assay for detecting recent HIV infection and 
estimating incidence. AIDS Res Hum Retroviruses 2002; 18: 295-307.
  8. Suligoi B, Massi M, Galli C, et al. Identifying recent HIV infections using the avidity index 
and an automated enzyme immunoassay. J Acquir Immune Defic Syndr 2003; 32: 424-428.
  9. Hu DJ, Vanichseni S, Mock PA, et al. HIV type 1 incidence estimates by detection of recent 
infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG 
capture BED enzyme immunoassay. AIDS Res Hum Retroviruses 2003; 19: 727-730.
10. Dobbs T, Kennedy S, Pau CP, et al. Performance characteristics of the immunoglobulin G-
capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency 
virus type 1 seroconversion. J Clin Microbiol 2004; 42: 2623-2628.
11. UNAIDS. Statement on the Use of the BED-assay for the Estimation of HIV-1 Incidence for 
Surveillance or Epidemic Monitoring.  Report of a meeting of the UNAIDS Reference Group 
for Estimates, Modelling and Projections. Athens, Greece, December 13-15, 2005.  Geneva: 
UNAIDS,  2005.
12. Centers for Disease Control, Surveillance and Survey and Laboratory Working Groups. 
Expert Meeting on the Validation of the BED HIV-1 Incidence Assay for HIV-1 Incidence 
Surveillance. Atlanta, Ga: CDC, 2006.
13. Centers for Disease Control, Surveillance and Survey and Laboratory Working Groups. 
Guidelines for the Use of the BED Capture Enzyme Immunoassay for Incidence Estimation and 
Surveillance. Atlanta, Ga: CDC, 2006.
14. Shisana O, Rehle T, Simbayi L, et al. South African National HIV Prevalence, HIV Incidence, 
Behaviour and Communication Survey, 2005. Cape Town: Human Sciences Research Council 
Publishers, 2005.
15. McDougal JS, Parekh, BS, Peterson ML, et al. Comparison of HIV-1 incidence observed 
during longitudinal follow-up with incidence estimated by cross-sectional analysis using the 
BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006; 22: 945-952.
16. Statistics South Africa. Mid-year Population Estimates, South Africa 2005. Pretoria: Statistics 
South Africa, 2005.
17. Shisana O, Simbayi L. Nelson Mandela/HSRC Study of HIV/AIDS: South African National HIV 
Prevalence, Behavioural Risks and Mass Media Household Survey 2002. Cape Town: Human 
Sciences Research Council Publishers, 2002.
18. Gray R, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, 
Uganda: a prospective study. Lancet 2005; 366: 1182-1188.
Accepted 11 January 2007.
March 2007, Vol. 97, No. 3  SAMJ
Pg 194-199.indd   199 2/16/07   2:26:29 PM
